孕期流感疫苗接种对儿童健康结局的有效性:系统综述与Meta分析
该系统综述与Meta分析检索1996年1月1日至2018年6月29日多个数据库并更新至2019年10月31日,纳入19项研究(15项观察性研究、4项主要随机对照试验及3篇报告这些随机对照试验次要结局的论文)。2项随机对照试验(5742名参与者)的Meta分析显示,孕期流感疫苗接种使婴儿实验室确诊流感总体降低34%(95%CI 15-50%);但未发现对≤6月龄婴儿流感样疾病有影响。观察性研究显示孕期接种与婴儿实验室确诊流感、因流感样疾病就诊或住院及≤6月龄婴儿其他呼吸道疾病呈反向(保护性)关联。
要点
- 2项随机对照试验(5742名参与者)Meta分析:孕期流感疫苗接种使婴儿实验室确诊流感降低34%(95%CI 15-50%)。
- 孕期流感疫苗接种对≤6月龄婴儿流感样疾病未见效果。
- 观察性研究显示孕期接种与婴儿实验室确诊流感、就诊或住院及≤6月龄其他呼吸道疾病呈保护性关联。
核心结论
- 该系统综述支持将孕期流感疫苗接种作为减少小婴儿实验室确诊流感及流感相关住院的策略。
- 将上述获益告知孕妇可能有助于其决定在孕期接种流感疫苗并提高孕妇疫苗接种覆盖率。
研究设计与样本
- 系统综述与Meta分析,检索ClinicalTrials.gov、Cochrane Library、EMBASE、Medline、Medline in process、PubMed和Web of Science,检索时间为1996年1月1日至2018年6月29日,并于2018年6月30日至2019年10月31日更新Medline检索。
- 纳入报告孕期接种灭活流感疫苗妇女所生婴儿和儿童健康结局的随机对照试验和观察性研究。
- 共纳入19项研究:15项观察性研究和4项主要随机对照试验,另加3篇报告这些随机对照试验次要结局的论文。
- 主要结局为婴儿实验室确诊流感,次要结局包括流感样疾病、其他呼吸道疾病、因流感疾病就诊、门诊就诊或住院以及儿童期长期呼吸结局。
主要发现
- 2项随机对照试验(5742名参与者)的随机效应Meta分析显示,孕期流感疫苗接种与婴儿实验室确诊流感总体降低34%(95%CI 15-50%)相关。
- 孕期流感疫苗接种对≤6月龄婴儿流感样疾病未见效果。
- 2项随机对照试验因婴儿实验室确诊流感结局所用对照不同而被排除于Meta分析,这两项研究均显示对婴儿实验室确诊流感有保护作用,疫苗效力最高达70%。
- 总体观察性研究显示孕期流感疫苗接种与婴儿实验室确诊流感、因实验室确诊流感或流感样疾病就诊或门诊就诊、住院以及≤6月龄婴儿其他呼吸道疾病呈反向(保护性)关联。
关键数值与推荐
- 孕期流感疫苗接种使婴儿实验室确诊流感降低34%(95%CI 15-50%),基于2项随机对照试验的5742名参与者。
- 被排除于Meta分析的2项随机对照试验显示婴儿实验室确诊流感疫苗效力最高达70%。
临床怎么用
- 该系统综述支持将孕期流感疫苗接种作为减少小婴儿实验室确诊流感及流感相关住院的策略。
- 将上述获益告知孕妇可能有助于其决定在孕期接种流感疫苗并提高孕妇疫苗接种覆盖率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the effectiveness of influenza vaccination during pregnancy on child health outcomes. DESIGN: Systematic review/meta-analysis. DATA SOURCES: Clinical Trials.gov, Cochrane Library, EMBASE, Medline, Medline in process, PubMed and Web of Science, from 1st January 1996 to 29th June 2018. An updated Medline search was performed 30th June 2018 to 31st October 2019. METHODS: Randomised controlled trials (RCTs) and observational studies reporting health outcomes of infants and children born to women who received inactivated influenza vaccine during pregnancy. The primary outcome was infant laboratory confirmed influenza (LCI). Secondary outcomes included influenza-like illness (ILI), other respiratory illnesses, primary care, clinic visit or hospitalisations due to influenza illness and long-term respiratory childhood outcomes. RESULTS: 19 studies were included; 15 observational studies and 4 primary RCTs with an additional 3 papers reporting secondary outcomes of these RCTs. In a random effects meta-analysis of 2 RCTs including 5742 participants, maternal influenza vaccination was associated with an overall reduction of LCI in infants of 34% (95% confidence interval 15-50%). However, there was no effect of maternal influenza vaccination on ILI in infants ≤6 months old. Two RCTs were excluded from the meta-analysis for the outcome of LCI in infants (different controls used). Both of these studies showed a protective effect for infants from LCI, with a vaccine efficacy of up to 70%. Overall observational studies showed an inverse (protective) association between maternal influenza vaccination and infant LCI, hospitalisation and clinic visits due to LCI or ILI in infants and other respiratory illness in infants ≤6 months old. CONCLUSIONS: This systematic review supports maternal influenza vaccination as a strategy to reduce LCI and influenza-related hospitalisations in young infants. Communicating these benefits to pregnant women may support their decision to accept influenza vaccination in pregnancy and increase vaccine coverage in pregnant women. REGISTRATION: PROSPERO CRD42018102776.
引用
- Jarvis JR, Dorey RB, Warricker FDM, et al. The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis. Vaccine. 2020. PMID: 31932138. doi:10.1016/j.vaccine.2019.12.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。